In vitro and in vivo evaluation of direct rhenium-188-labeled anti-CD52 monoclonal antibody alemtuzumab for radioimmunotherapy of B-cell chronic lymphocytic leukemiaMario De Decker, Filip De Vos, Klaus Bacher et al.|Nuclear Medicine and Biology|2008Cited by 29